Tevogen Bio Holdings Inc
TVGN
NASDAQ
Biotechnology
$6.87
USD
+0.30 (+4.57%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $42.16M
Volume 8.2K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-21.35M
TTM
+39.6%
YoY
Operating Cash Flow
$-11.75M
TTM
+10.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 7.2 | 2.7 | 2.6 | 2.5 | 2.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 10.4 | 5.4 | 5.7 | 4.6 | 5.4 |
Operating Income | -10.4 | -5.4 | -5.7 | -4.6 | -5.4 |
EBITDA | -10.3 | -5.4 | -5.7 | -4.2 | -5.4 |
Other Income / Expense | 0.0 | -0.0 | 0.1 | 0.0 | 0.0 |
Total Other Income / Expense | -0.0 | -0.1 | 0.0 | -0.1 | -0.0 |
Income Before Income Taxes | -10.4 | -5.5 | -5.7 | -4.7 | -5.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -10.4 | -5.5 | -5.7 | -4.7 | -5.4 |
Consolidated Net Income / Loss | -10.4 | -5.5 | -5.7 | -4.7 | -5.4 |
Net Income Attributable to Common Shareholders | -10.5 | -5.5 | -5.7 | -5.2 | -5.6 |
Basic EPS | -$3.25 | -$1.50 | -$1.50 | -$2.14 | -$1.61 |
Diluted EPS | -$3.25 | -$1.50 | -$1.50 | -$2.14 | -$1.61 |
Basic Shares Outstanding | 3.2M | 3.7M | 3.9M | 2.4M | 3.5M |
Diluted Shares Outstanding | 3.2M | 3.7M | 3.9M | 2.4M | 3.5M |